Clinical and Pathological Characteristics of the Mammary Paget's Disease: A Single-Center Retrospective Study in

Ryusei Yoshino1, Masahiro Kitada1, Takumi Inao1

  • 1Department of Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Asahikawa, Japan.

Cancer Investigation
|November 3, 2025
PubMed

Insights

Human epidermal growth factor receptor 2 (HER2)-positive Mammary Paget's disease (MPD) shows aggressive behavior but is hard to diagnose. Magnetic resonance imaging (MRI) aids in detecting HER2-positive MPD, crucial for effective treatment.

Area of Science:

  • Oncology
  • Radiology
  • Pathology

Background:

  • Mammary Paget's disease (MPD) is a rare breast cancer often linked to other breast cancers.
  • Diagnosis of MPD is difficult due to subtle or absent signs on standard imaging.

Purpose of the Study:

  • To investigate the characteristics of HER2-positive MPD in a Japanese cohort.
  • To evaluate the role of MRI in diagnosing HER2-positive MPD.

Main Methods:

  • Retrospective analysis of 12 Japanese patients with MPD.
  • Assessed HER2 overexpression (immunohistochemistry), associated ductal carcinoma in situ, MRI findings, and Ki-67 proliferation index.
  • Correlated imaging findings with pathological results.

Main Results:

  • All patients had HER2 overexpression (3+), and 92% had associated ductal carcinoma in situ.
  • MRI detected skin/nipple enhancement in 78%, non-mass enhancement, and nipple thickening.
  • High Ki-67 index (median 67%) indicated active tumors. No recurrence or death during median 96-month follow-up.

Conclusions:

  • HER2-positive MPD exhibits aggressive biological traits despite subtle clinical signs.
  • MRI is valuable for detecting HER2-positive MPD.
  • Integrating imaging with pathology and molecular markers is key for MPD diagnosis and treatment.